Skip to content

Clinical Trial of Lamotrigine to Reverse Cognitive Impairment in Chronic Corticosteroid-Treated Patients

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00223262
Enrollment
28
Registered
2005-09-22
Start date
2002-08-31
Completion date
2005-09-30
Last updated
2019-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hippocampal Atrophy Due to Corticosteroid, Hypomania Due to Corticosteroid Use, Memory Impairment Due to Corticosteroid Use

Brief summary

The purpose of this study is to determine if lamotrigine therapy is associated with improvement in mood, memory and hippocampal size and function in patients receiving chronic corticosteroid therapy. Standard care for mood changes associated with corticosteroid therapy, if severe, includes antidepressants or other medications which can influence mood. No therapies, other than dose reduction or discontinuation, are currently available for memory loss associated with corticosteroid treatment. However, very little information is available on the treatment of either mood or memory changes associated with corticosteroid treatment, thus the proposed project may improve standard care.

Interventions

Sponsors

University of Texas Southwestern Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years

Inclusion criteria

* Current Corticosteroid Use of 7 mg or more for 6+ months * 18-65 years of age

Exclusion criteria

* Primarily non-English speaking * Pregnant/nursing woman * Currently taking Depakote * Currently taking Rifampin * Has diagnosis of major depressive disorder, schizophrenia, PTSD, bipolar I or bipolar II (not related to corticosteroid use) * Diseases with CNS involvement * Is to start a brief steroid taper * History of Alcohol/drug abuse/dependence

Design outcomes

Primary

MeasureTime frameDescription
Rey Auditory Verbal Learning Test (RAVLT)24 weeksRey Auditory Verbal Learning Test (RAVLT) is a test of verbal learning and declarative memory. During the test, 15 nouns that are read aloud for 5 consecutive trials. Each trial is followed by a free recall test (participant is asked to recall the words that were just read to them). The sum of correctly recalled words across 5 trials is called the total raw score. On completion of Trial 5, an interference list of 15 words (List B) is presented, followed by a free recall test of that list. After a 20-min delay, the examinee is again required to recall the words from list A - this is called the delay raw score. The raw scores on both the total recall and the delay trials (number of words correct across trials 1-5) are converted to standardized T-scores (Mean=50; SD=10; range 20-100) based on participant age and gender. The scores below are presented as T-scores, with higher scores indicative of better performance.

Countries

United States

Participant flow

Participants by arm

ArmCount
Lamotrigine
Lamotrigine was initiated at 25 mg/day for 2 weeks, increased to 50 mg/day for 2 weeks, and then increased in 50 mg/day increments weekly to a dose of 400 mg/day at week 10 using a fixed dosing schedule.
8
Placebo
Matched placebo identical in appearance to the active drug.
11
Total19

Baseline characteristics

CharacteristicLamotriginePlaceboTotal
Age, Continuous44.6 years
STANDARD_DEVIATION 11.2
47.4 years
STANDARD_DEVIATION 13.3
46.0 years
STANDARD_DEVIATION 12.3
Region of Enrollment
United States
8 participants11 participants19 participants
Sex: Female, Male
Female
1 Participants3 Participants4 Participants
Sex: Female, Male
Male
7 Participants8 Participants15 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 80 / 11
other
Total, other adverse events
0 / 80 / 11
serious
Total, serious adverse events
0 / 80 / 11

Outcome results

Primary

Rey Auditory Verbal Learning Test (RAVLT)

Rey Auditory Verbal Learning Test (RAVLT) is a test of verbal learning and declarative memory. During the test, 15 nouns that are read aloud for 5 consecutive trials. Each trial is followed by a free recall test (participant is asked to recall the words that were just read to them). The sum of correctly recalled words across 5 trials is called the total raw score. On completion of Trial 5, an interference list of 15 words (List B) is presented, followed by a free recall test of that list. After a 20-min delay, the examinee is again required to recall the words from list A - this is called the delay raw score. The raw scores on both the total recall and the delay trials (number of words correct across trials 1-5) are converted to standardized T-scores (Mean=50; SD=10; range 20-100) based on participant age and gender. The scores below are presented as T-scores, with higher scores indicative of better performance.

Time frame: 24 weeks

ArmMeasureValue (MEAN)Dispersion
LamotrigineRey Auditory Verbal Learning Test (RAVLT)46.1 T-scoresStandard Deviation 15
PlaceboRey Auditory Verbal Learning Test (RAVLT)40.1 T-scoresStandard Deviation 11

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026